fluticasone propionate 115 MCG / salmeterol 21 MCG (salmeterol xinafoate 30.45 MCG) per ACTUAT Metered Dose Inhaler, 120 ACTUAT
- RxCUI
- 896244
- RxNorm name
- fluticasone propionate 115 MCG / salmeterol 21 MCG (salmeterol xinafoate 30.45 MCG) per ACTUAT Metered Dose Inhaler, 120 ACTUAT
- Display name
- fluticasone propionate 115 MCG / salmeterol 21 MCG (salmeterol xinafoate 30.45 MCG) per ACTUAT Metered Dose Inhaler, 120 ACTUAT
- Full name
- fluticasone propionate 115 MCG / salmeterol 21 MCG (salmeterol xinafoate 30.45 MCG) per ACTUAT Metered Dose Inhaler, 120 ACTUAT
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:24
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ADVAIR HFA | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | A-S Medication Solutions | 80b36523-4ae4-463e-b1fd-b929fb802b76 | 2025-08-08 | Warnings, Adverse reactions | 896244 |
| ADVAIR HFA | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | A-S Medication Solutions | 223fd5d4-3bd2-4e45-b72e-699438c32206 | 2025-08-08 | Warnings, Adverse reactions | 896244 |
| Fluticasone Propionate and Salmeterol HFA | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | Prasco Laboratories | 666c5b12-a4f7-4c53-8261-4742b5e5a6df | 2024-05-29 | Warnings, Adverse reactions | 896244 |
| ADVAIR HFA | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | GlaxoSmithKline LLC | dfaca6f9-3277-47b2-319d-1377917cb54c | 2024-05-23 | Warnings, Adverse reactions | 896244 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| dfaca6f9-3277-47b2-319d-1377917cb54c | fluticasone propionate/salmeterol 115/21 MCG/INHAL Metered Dose Inhaler, 120 Actuations | PSN | 37 | These highlights do not include all the information needed to use ADVAIR HFA safely and effectively. See full prescribing information for ADVAIR HFA. ADVAIR HFA (fluticasone propionate and salmeterol inhalation aerosol), for oral inhalation use Initial U.S. Approval: 2000 | 20240523 |
| dfaca6f9-3277-47b2-319d-1377917cb54c | 120 ACTUAT fluticasone propionate 0.115 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler | SCD | 37 | These highlights do not include all the information needed to use ADVAIR HFA safely and effectively. See full prescribing information for ADVAIR HFA. ADVAIR HFA (fluticasone propionate and salmeterol inhalation aerosol), for oral inhalation use Initial U.S. Approval: 2000 | 20240523 |
| dfaca6f9-3277-47b2-319d-1377917cb54c | fluticasone propionate 0.115 MG / salmeterol 0.021 MG per ACTUAT Metered Dose Inhaler, 120 ACTUAT | SY | 37 | These highlights do not include all the information needed to use ADVAIR HFA safely and effectively. See full prescribing information for ADVAIR HFA. ADVAIR HFA (fluticasone propionate and salmeterol inhalation aerosol), for oral inhalation use Initial U.S. Approval: 2000 | 20240523 |
| dfaca6f9-3277-47b2-319d-1377917cb54c | fluticasone propionate 115 MCG / salmeterol 21 MCG (salmeterol xinafoate 30.45 MCG) per ACTUAT Metered Dose Inhaler, 120 ACTUAT | SY | 37 | These highlights do not include all the information needed to use ADVAIR HFA safely and effectively. See full prescribing information for ADVAIR HFA. ADVAIR HFA (fluticasone propionate and salmeterol inhalation aerosol), for oral inhalation use Initial U.S. Approval: 2000 | 20240523 |
| 223fd5d4-3bd2-4e45-b72e-699438c32206 | fluticasone propionate 0.115 MG / salmeterol 0.021 MG per ACTUAT Metered Dose Inhaler, 120 ACTUAT | SY | 13 | These highlights do not include all the information needed to use ADVAIR HFA safely and effectively. See full prescribing information for ADVAIR HFA. ADVAIR HFA (fluticasone propionate and salmeterol inhalation aerosol), for oral inhalation use Initial U.S. Approval: 2000 | 20250808 |
| 223fd5d4-3bd2-4e45-b72e-699438c32206 | fluticasone propionate/salmeterol 115/21 MCG/INHAL Metered Dose Inhaler, 120 Actuations | PSN | 13 | These highlights do not include all the information needed to use ADVAIR HFA safely and effectively. See full prescribing information for ADVAIR HFA. ADVAIR HFA (fluticasone propionate and salmeterol inhalation aerosol), for oral inhalation use Initial U.S. Approval: 2000 | 20250808 |
| 223fd5d4-3bd2-4e45-b72e-699438c32206 | 120 ACTUAT fluticasone propionate 0.115 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler | SCD | 13 | These highlights do not include all the information needed to use ADVAIR HFA safely and effectively. See full prescribing information for ADVAIR HFA. ADVAIR HFA (fluticasone propionate and salmeterol inhalation aerosol), for oral inhalation use Initial U.S. Approval: 2000 | 20250808 |
| 223fd5d4-3bd2-4e45-b72e-699438c32206 | fluticasone propionate 115 MCG / salmeterol 21 MCG (salmeterol xinafoate 30.45 MCG) per ACTUAT Metered Dose Inhaler, 120 ACTUAT | SY | 13 | These highlights do not include all the information needed to use ADVAIR HFA safely and effectively. See full prescribing information for ADVAIR HFA. ADVAIR HFA (fluticasone propionate and salmeterol inhalation aerosol), for oral inhalation use Initial U.S. Approval: 2000 | 20250808 |
| 80b36523-4ae4-463e-b1fd-b929fb802b76 | fluticasone propionate 115 MCG / salmeterol 21 MCG (salmeterol xinafoate 30.45 MCG) per ACTUAT Metered Dose Inhaler, 120 ACTUAT | SY | 5 | These highlights do not include all the information needed to use ADVAIR HFA safely and effectively. See full prescribing information for ADVAIR HFA. ADVAIR HFA (fluticasone propionate and salmeterol inhalation aerosol), for oral inhalation use Initial U.S. Approval: 2000 | 20250808 |
| 80b36523-4ae4-463e-b1fd-b929fb802b76 | fluticasone propionate 0.115 MG / salmeterol 0.021 MG per ACTUAT Metered Dose Inhaler, 120 ACTUAT | SY | 5 | These highlights do not include all the information needed to use ADVAIR HFA safely and effectively. See full prescribing information for ADVAIR HFA. ADVAIR HFA (fluticasone propionate and salmeterol inhalation aerosol), for oral inhalation use Initial U.S. Approval: 2000 | 20250808 |
| 80b36523-4ae4-463e-b1fd-b929fb802b76 | 120 ACTUAT fluticasone propionate 0.115 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler | SCD | 5 | These highlights do not include all the information needed to use ADVAIR HFA safely and effectively. See full prescribing information for ADVAIR HFA. ADVAIR HFA (fluticasone propionate and salmeterol inhalation aerosol), for oral inhalation use Initial U.S. Approval: 2000 | 20250808 |
| 80b36523-4ae4-463e-b1fd-b929fb802b76 | fluticasone propionate/salmeterol 115/21 MCG/INHAL Metered Dose Inhaler, 120 Actuations | PSN | 5 | These highlights do not include all the information needed to use ADVAIR HFA safely and effectively. See full prescribing information for ADVAIR HFA. ADVAIR HFA (fluticasone propionate and salmeterol inhalation aerosol), for oral inhalation use Initial U.S. Approval: 2000 | 20250808 |
| 666c5b12-a4f7-4c53-8261-4742b5e5a6df | fluticasone propionate/salmeterol 115/21 MCG/INHAL Metered Dose Inhaler, 120 Actuations | PSN | 5 | These highlights do not include all the information needed to use Fluticasone Propionate and Salmeterol HFA safely and effectively. See full prescribing information for Fluticasone Propionate and Salmeterol HFA. Fluticasone Propionate and Salmeterol HFA inhalation aerosol, for oral inhalation use Initial U.S. Approval: 2000 | 20240529 |
| 666c5b12-a4f7-4c53-8261-4742b5e5a6df | fluticasone propionate 115 MCG / salmeterol 21 MCG (salmeterol xinafoate 30.45 MCG) per ACTUAT Metered Dose Inhaler, 120 ACTUAT | SY | 5 | These highlights do not include all the information needed to use Fluticasone Propionate and Salmeterol HFA safely and effectively. See full prescribing information for Fluticasone Propionate and Salmeterol HFA. Fluticasone Propionate and Salmeterol HFA inhalation aerosol, for oral inhalation use Initial U.S. Approval: 2000 | 20240529 |
| 666c5b12-a4f7-4c53-8261-4742b5e5a6df | 120 ACTUAT fluticasone propionate 0.115 MG/ACTUAT / salmeterol 0.021 MG/ACTUAT Metered Dose Inhaler | SCD | 5 | These highlights do not include all the information needed to use Fluticasone Propionate and Salmeterol HFA safely and effectively. See full prescribing information for Fluticasone Propionate and Salmeterol HFA. Fluticasone Propionate and Salmeterol HFA inhalation aerosol, for oral inhalation use Initial U.S. Approval: 2000 | 20240529 |
| 666c5b12-a4f7-4c53-8261-4742b5e5a6df | fluticasone propionate 0.115 MG / salmeterol 0.021 MG per ACTUAT Metered Dose Inhaler, 120 ACTUAT | SY | 5 | These highlights do not include all the information needed to use Fluticasone Propionate and Salmeterol HFA safely and effectively. See full prescribing information for Fluticasone Propionate and Salmeterol HFA. Fluticasone Propionate and Salmeterol HFA inhalation aerosol, for oral inhalation use Initial U.S. Approval: 2000 | 20240529 |